Richard Albert Stein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Richard Albert Stein has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
Adi Katz
MD, Department of Obstetrics and Gynecology, Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra Northwell, 110 E 77th Street, New York, NY, 10075, USA
5 shared publicationsLeise Riber
University of Copenhagen
3 shared publicationsOana Ometa
PhD, Department of Journalism and Digital Media, Faculty of Political, Administrative and Communication Sciences, Babes-Bolyai University, Cluj-Napoca, Romania
3 shared publicationsAbhi N. Deverakonda
NYU Tandon School of Engineering, Department of Chemical and Biomolecular Engineering, Brooklyn, NY
2 shared publicationsDavid E. Katz
Department of Internal Medicine, Shaare Zedek Medical Center, Hebrew University School of Medicine, Jerusalem 91031, Israel
2 shared publications- Devra Lee Davis
Environmental Health Trust, P.O. Box 58, Teton Village, WY 83025, USA
2 shared publications
Latest Publications
- 10 June 2026
- Published by American Physiological Society in Physiological Genomics
- Vol. 58 (8) , 355-378
Akkermansia muciniphila : a member of the gut microbiota that modulates intestinal stem cell function
Akkermansia muciniphila, a commensal bacterium that represents 1-4% of the fecal microbiota in healthy adults, and can use mucin as a sole source of carbon and nitrogen, has attracted interest as soon as it was discovered due to the relationship between its abundance and various benefits, particularly pertaining to metabolic health. Especially noteworthy is the finding that A. muciniphila stimulates the proliferation and differentiation of intestinal stem cells, as part of tissue homeostasis and repair after biological, chemical, or physical injury. In this review, we discuss some of the evidence that supports the ability of A. muciniphila and of specific bacterial proteins to support the intestinal stem cell niche. The additional finding that some of these benefits are exerted during gestation on fetal stem cells, persist into adulthood, and influence crypt regeneration after injury, suggests that A. muciniphila may be part of the gestational environment that shapes the health of offspring. While most A. muciniphila health benefits were characterized using Muc T (A. muciniphila ATCC BAA-835), the discovery of large phylogenetic and functional diversity within the Akkermansia genus galvanized efforts to compare different strains for their individual health profiles. Even closely related A. muciniphila strains may not always share the same health benefits, and sometimes the same strain may be beneficial or harmful depending on host-related factors, pointing towards the need to characterize health phenotypes at the strain level and in context of the host, and underscoring the ongoing gaps in defining the optimal formulation and safety profile of individual strains.
- 10 June 2026
- Published by American Physiological Society in Physiological Genomics
- Vol. 58 (8) , 355-378
Akkermansia muciniphila : a member of the gut microbiota that modulates intestinal stem cell function
Akkermansia muciniphila, a commensal bacterium that represents 1-4% of the fecal microbiota in healthy adults, and can use mucin as a sole source of carbon and nitrogen, has attracted interest as soon as it was discovered due to the relationship between its abundance and various benefits, particularly pertaining to metabolic health. Especially noteworthy is the finding that A. muciniphila stimulates the proliferation and differentiation of intestinal stem cells, as part of tissue homeostasis and repair after biological, chemical, or physical injury. In this review, we discuss some of the evidence that supports the ability of A. muciniphila and of specific bacterial proteins to support the intestinal stem cell niche. The additional finding that some of these benefits are exerted during gestation on fetal stem cells, persist into adulthood, and influence crypt regeneration after injury, suggests that A. muciniphila may be part of the gestational environment that shapes the health of offspring. While most A. muciniphila health benefits were characterized using Muc T (A. muciniphila ATCC BAA-835), the discovery of large phylogenetic and functional diversity within the Akkermansia genus galvanized efforts to compare different strains for their individual health profiles. Even closely related A. muciniphila strains may not always share the same health benefits, and sometimes the same strain may be beneficial or harmful depending on host-related factors, pointing towards the need to characterize health phenotypes at the strain level and in context of the host, and underscoring the ongoing gaps in defining the optimal formulation and safety profile of individual strains.
- 15 September 2024
- Published by Springer Nature
- p. 119-168
The Epigenetic Impact of the Human Microbiota on Host Cells
- 15 September 2024
- Published by Springer Nature
- p. 119-168
The Epigenetic Impact of the Human Microbiota on Host Cells
- 9 September 2024
- Published by American Physiological Society in Physiological Genomics
- Vol. 56 (11) , 741-763
Then and Now in Eukaryotic DNA Methylation
Since the mid-1970s, increasingly innovative methods to detect DNA methylation provided detailed information about its distribution, functions, and dynamics. As a result, new concepts were formulated and older ones were revised, transforming our understanding of the associated biology and catalyzing unprecedented advances in biomedical research, drug development, anthropology, and evolutionary biology. In this review, we discuss a few of the most notable advances, which are intimately intertwined with the study of DNA methylation, with a particular emphasis on the past three decades. Examples of these strides include elucidating the intricacies of 5-mC oxidation, which are at the core of the reversibility of this epigenetic modification; the 3D structural characterization of eukaryotic DNA methyltransferases, which offered insights into the mechanisms of several disease-associated mutations; a more in-depth understanding of DNA methylation in development and disease; the possibility to learn about the biology of extinct species; the development of epigenetic clocks and their use to interrogate aging and disease; and the emergence of epigenetic biomarkers and therapies.
- 9 September 2024
- Published by American Physiological Society in Physiological Genomics
- Vol. 56 (11) , 741-763
Then and Now in Eukaryotic DNA Methylation
Since the mid-1970s, increasingly innovative methods to detect DNA methylation provided detailed information about its distribution, functions, and dynamics. As a result, new concepts were formulated and older ones were revised, transforming our understanding of the associated biology and catalyzing unprecedented advances in biomedical research, drug development, anthropology, and evolutionary biology. In this review, we discuss a few of the most notable advances, which are intimately intertwined with the study of DNA methylation, with a particular emphasis on the past three decades. Examples of these strides include elucidating the intricacies of 5-mC oxidation, which are at the core of the reversibility of this epigenetic modification; the 3D structural characterization of eukaryotic DNA methyltransferases, which offered insights into the mechanisms of several disease-associated mutations; a more in-depth understanding of DNA methylation in development and disease; the possibility to learn about the biology of extinct species; the development of epigenetic clocks and their use to interrogate aging and disease; and the emergence of epigenetic biomarkers and therapies.
- 2 April 2024
- Published by Springer Nature
- p. 439-473
Politicisation of Science and Health Topics
- Open Access
- 16 June 2023
- Published by Oxford University Press (OUP) in microLife
- Vol. 4, uqad032
Epigenetic effects of short-chain fatty acids from the large intestine on host cells
Adult humans harbor at least as many microbial cells as eukaryotic ones. The largest compartment of this diverse microbial population, the gut microbiota, encompasses the collection of bacteria, archaea, viruses, and eukaryotic organisms that populate the gastrointestinal tract, and represents a complex and dynamic ecosystem that has been increasingly implicated in health and disease. The gut microbiota carries ∼100-to-150-times more genes than the human genome and is intimately involved in development, homeostasis, and disease. Of the several microbial metabolites that have been studied, short-chain fatty acids emerge as a group of molecules that shape gene expression in several types of eukaryotic cells by multiple mechanisms, which include DNA methylation changes, histone post-translational modifications, and microRNA-mediated gene silencing. Butyric acid, one of the most extensively studied short-chain fatty acids, reaches higher concentrations in the colonic lumen, where it provides a source of energy for healthy colonocytes, and its concentrations decrease towards the bottom of the colonic crypts, where stem cells reside. The lower butyric acid concentration in the colonic crypts allows undifferentiated cells, such as stem cells, to progress through the cell cycle, pointing towards the importance of the crypts in providing them with a protective niche. In cancerous colonocytes, which metabolize relatively little butyric acid and mostly rely on glycolysis, butyric acid preferentially acts as a histone deacetylase inhibitor, leading to decreased cell proliferation and increased apoptosis. A better understanding of the interface between the gut microbiota metabolites and epigenetic changes in eukaryotic cells promises to unravel in more detail processes that occur physiologically and as part of disease, help develop novel biomarkers, and identify new therapeutic modalities.
- 16 June 2023
- Published by Oxford University Press (OUP) in microLife
- Vol. 4, uqad032
Open AccessEpigenetic effects of short-chain fatty acids from the large intestine on host cells
Adult humans harbor at least as many microbial cells as eukaryotic ones. The largest compartment of this diverse microbial population, the gut microbiota, encompasses the collection of bacteria, archaea, viruses, and eukaryotic organisms that populate the gastrointestinal tract, and represents a complex and dynamic ecosystem that has been increasingly implicated in health and disease. The gut microbiota carries ∼100-to-150-times more genes than the human genome and is intimately involved in development, homeostasis, and disease. Of the several microbial metabolites that have been studied, short-chain fatty acids emerge as a group of molecules that shape gene expression in several types of eukaryotic cells by multiple mechanisms, which include DNA methylation changes, histone post-translational modifications, and microRNA-mediated gene silencing. Butyric acid, one of the most extensively studied short-chain fatty acids, reaches higher concentrations in the colonic lumen, where it provides a source of energy for healthy colonocytes, and its concentrations decrease towards the bottom of the colonic crypts, where stem cells reside. The lower butyric acid concentration in the colonic crypts allows undifferentiated cells, such as stem cells, to progress through the cell cycle, pointing towards the importance of the crypts in providing them with a protective niche. In cancerous colonocytes, which metabolize relatively little butyric acid and mostly rely on glycolysis, butyric acid preferentially acts as a histone deacetylase inhibitor, leading to decreased cell proliferation and increased apoptosis. A better understanding of the interface between the gut microbiota metabolites and epigenetic changes in eukaryotic cells promises to unravel in more detail processes that occur physiologically and as part of disease, help develop novel biomarkers, and identify new therapeutic modalities.
- 1 June 2023
- Published by American Physiological Society in Physiological Genomics
- Vol. 55 (6) , 249-258
Human endogenous retroviruses: our genomic fossils and companions
Approximately 8% of the human genome, over four times more than its protein-coding regions, comprises sequences of viral origin that are known as human endogenous retroviral elements (HERVs). Present in the genome of all human cells, HERVs resulted from the integration of now-extinct exogenous retroviruses into mammalian ancestor germ cells or their precursors on several occasions, sometimes as long as tens of millions of years ago. Most HERVs have become silenced because of mutations such as substitutions, insertions, or deletions, and as a result of epigenetic changes, and are vertically transmitted in the population. Considered for a long time to be part of the “junk DNA,” HERVs were shown, in more recent years, to perform critical functions in the host. Two of the very few HERVs known to encode functional proteins, syncytin-1 and syncytin-2, are critical during embryogenesis, when they contribute to the formation of the placenta and facilitate tolerance of the maternal immune system toward the developing fetus. Homologs of syncytin-encoding genes were described in several other species, and it appears that during evolution they were stably endogenized into the respective genomes on multiple occasions and became co-opted for critical physiological functions. The aberrant expression of HERVs has been linked to conditions that include infectious, autoimmune, malignant, and neurological diseases. HERVs, our genomic fossils and storytellers, provide a fascinating and somewhat mysterious insight into our co-evolution with viruses, and will undoubtedly offer many teachings, surprises, and paradigm changes for years to come.
- 1 June 2023
- Published by American Physiological Society in Physiological Genomics
- Vol. 55 (6) , 249-258
Human endogenous retroviruses: our genomic fossils and companions
Approximately 8% of the human genome, over four times more than its protein-coding regions, comprises sequences of viral origin that are known as human endogenous retroviral elements (HERVs). Present in the genome of all human cells, HERVs resulted from the integration of now-extinct exogenous retroviruses into mammalian ancestor germ cells or their precursors on several occasions, sometimes as long as tens of millions of years ago. Most HERVs have become silenced because of mutations such as substitutions, insertions, or deletions, and as a result of epigenetic changes, and are vertically transmitted in the population. Considered for a long time to be part of the “junk DNA,” HERVs were shown, in more recent years, to perform critical functions in the host. Two of the very few HERVs known to encode functional proteins, syncytin-1 and syncytin-2, are critical during embryogenesis, when they contribute to the formation of the placenta and facilitate tolerance of the maternal immune system toward the developing fetus. Homologs of syncytin-encoding genes were described in several other species, and it appears that during evolution they were stably endogenized into the respective genomes on multiple occasions and became co-opted for critical physiological functions. The aberrant expression of HERVs has been linked to conditions that include infectious, autoimmune, malignant, and neurological diseases. HERVs, our genomic fossils and storytellers, provide a fascinating and somewhat mysterious insight into our co-evolution with viruses, and will undoubtedly offer many teachings, surprises, and paradigm changes for years to come.
- 17 January 2023
- Published by Oxford University Press (OUP) in Pathogens and Disease
- Vol. 81
Epigenetic changes induced by pathogenic Chlamydia spp
Chlamydia trachomatis, C. pneumoniae, and C. psittaci, the three Chlamydia species known to cause human disease, have been collectively linked to several pathologies, including conjunctivitis, trachoma, respiratory disease, acute and chronic urogenital infections and their complications, and psittacosis. In vitro, animal, and human studies also established additional correlations, such as between C. pneumoniae and atherosclerosis and between C. trachomatis and ovarian cancer. As part of their survival and pathogenesis strategies as obligate intracellular bacteria, Chlamydia spp. modulate all three major types of epigenetic changes, which include DNA methylation, histone post-translational modifications, and microRNA-mediated gene silencing. Some of these epigenetic changes may be implicated in key aspects of pathogenesis, such as the ability of the Chlamydia spp. to induce epithelial-to-mesenchymal transition, interfere with DNA damage repair, suppress cholesterol efflux from infected macrophages, act as a co-factor in HPV-mediated cervical cancer, prevent apoptosis, and preserve the integrity of mitochondrial networks in infected host cells. A better understanding of the individual and collective contribution of epigenetic changes to pathogenesis will enhance our knowledge about the biology of Chlamydia spp. and facilitate the development of novel therapies and biomarkers.
- 17 January 2023
- Published by Oxford University Press (OUP) in Pathogens and Disease
- Vol. 81
Epigenetic changes induced by pathogenic Chlamydia spp
Chlamydia trachomatis, C. pneumoniae, and C. psittaci, the three Chlamydia species known to cause human disease, have been collectively linked to several pathologies, including conjunctivitis, trachoma, respiratory disease, acute and chronic urogenital infections and their complications, and psittacosis. In vitro, animal, and human studies also established additional correlations, such as between C. pneumoniae and atherosclerosis and between C. trachomatis and ovarian cancer. As part of their survival and pathogenesis strategies as obligate intracellular bacteria, Chlamydia spp. modulate all three major types of epigenetic changes, which include DNA methylation, histone post-translational modifications, and microRNA-mediated gene silencing. Some of these epigenetic changes may be implicated in key aspects of pathogenesis, such as the ability of the Chlamydia spp. to induce epithelial-to-mesenchymal transition, interfere with DNA damage repair, suppress cholesterol efflux from infected macrophages, act as a co-factor in HPV-mediated cervical cancer, prevent apoptosis, and preserve the integrity of mitochondrial networks in infected host cells. A better understanding of the individual and collective contribution of epigenetic changes to pathogenesis will enhance our knowledge about the biology of Chlamydia spp. and facilitate the development of novel therapies and biomarkers.
- Open Access
The Zika virus: an opportunity to revisit reproductive health needs and disparities
First isolated in 1947, the Zika virus was initially connected only to limited or sporadic human infections. In late 2015, the temporal clustering of a Zika outbreak and microcephaly in newborn babies from northeastern Brazil, and the identification of a causal link between the two, led to the characterization of the congenital Zika syndrome. In the wake of the epidemic, several countries from Latin America advised women to postpone pregnancies for periods ranging from six months to two years. These recommendations initiated critical conversations about the challenges of implementing them in societies with limited access to contraception, widespread socioeconomic inequalities, and high rates of unplanned and adolescent pregnancies. The messaging targeted exclusively women, despite a high prevalence of imbalances in the relationship power, and addressed all women as a group, failing to recognize that the decision to postpone pregnancies will impact different women in different ways, depending on their age at the time. Finally, in several countries affected by the Zika epidemic, due to restrictive reproductive policies, legally terminating a pregnancy is no longer an option even at the earliest time when brain malformations as part of the congenital Zika syndrome can be detected by ultrasonography. The virus continued to circulate after 2016 in several countries. Climate change models predict an expansion of the geographical area where local Zika transmission may occur, indicating that the interface between the virus, teratogenesis, and reproductive rights is a topic of considerable interest for medicine, social sciences, and public health for years to come.
Open AccessThe Zika virus: an opportunity to revisit reproductive health needs and disparities
First isolated in 1947, the Zika virus was initially connected only to limited or sporadic human infections. In late 2015, the temporal clustering of a Zika outbreak and microcephaly in newborn babies from northeastern Brazil, and the identification of a causal link between the two, led to the characterization of the congenital Zika syndrome. In the wake of the epidemic, several countries from Latin America advised women to postpone pregnancies for periods ranging from six months to two years. These recommendations initiated critical conversations about the challenges of implementing them in societies with limited access to contraception, widespread socioeconomic inequalities, and high rates of unplanned and adolescent pregnancies. The messaging targeted exclusively women, despite a high prevalence of imbalances in the relationship power, and addressed all women as a group, failing to recognize that the decision to postpone pregnancies will impact different women in different ways, depending on their age at the time. Finally, in several countries affected by the Zika epidemic, due to restrictive reproductive policies, legally terminating a pregnancy is no longer an option even at the earliest time when brain malformations as part of the congenital Zika syndrome can be detected by ultrasonography. The virus continued to circulate after 2016 in several countries. Climate change models predict an expansion of the geographical area where local Zika transmission may occur, indicating that the interface between the virus, teratogenesis, and reproductive rights is a topic of considerable interest for medicine, social sciences, and public health for years to come.
- 11 November 2022
- Published by Taylor & Francis in The European Journal of Contraception & Reproductive Health Care
- Vol. 28 (1) , 23-27
The far-reaching impact of abortion bans: reproductive care and beyond
On 24 June 2022, the US Supreme Court overturned Roe v. Wade, a 49-year-old precedent that provided federal constitutional protection for abortions up to the point of foetal viability, returning jurisdiction to the individual states. Restrictions that came into effect automatically in several states, and are anticipated in others, will severely limit access to abortions in approximately half of the US. Even though every state allows for exceptions to the abortion bans, in some instances these exceptions can be used to preserve the health of a pregnant patient, while in other instances, only to preserve their life. The vague and confusing nature of the abortion ban exceptions threatens to compromise the standard of care for patients with pregnancy complications that are distinct from abortions, such as nonviable pregnancies, miscarriages, and ectopic pregnancies. Additionally, we envision challenges for the treatment of women with certain autoimmune conditions, pregnant cancer patients, and patients contemplating preimplantation genetic diagnosis as part of assisted reproductive technologies. The abortion ban exceptions will impact and interfere with the medical care of pregnant and non-pregnant patient populations alike and are poised to create a medical and public health crisis unlike any other one from the recent past.
- 11 November 2022
- Published by Taylor & Francis in The European Journal of Contraception & Reproductive Health Care
- Vol. 28 (1) , 23-27
The far-reaching impact of abortion bans: reproductive care and beyond
On 24 June 2022, the US Supreme Court overturned Roe v. Wade, a 49-year-old precedent that provided federal constitutional protection for abortions up to the point of foetal viability, returning jurisdiction to the individual states. Restrictions that came into effect automatically in several states, and are anticipated in others, will severely limit access to abortions in approximately half of the US. Even though every state allows for exceptions to the abortion bans, in some instances these exceptions can be used to preserve the health of a pregnant patient, while in other instances, only to preserve their life. The vague and confusing nature of the abortion ban exceptions threatens to compromise the standard of care for patients with pregnancy complications that are distinct from abortions, such as nonviable pregnancies, miscarriages, and ectopic pregnancies. Additionally, we envision challenges for the treatment of women with certain autoimmune conditions, pregnant cancer patients, and patients contemplating preimplantation genetic diagnosis as part of assisted reproductive technologies. The abortion ban exceptions will impact and interfere with the medical care of pregnant and non-pregnant patient populations alike and are poised to create a medical and public health crisis unlike any other one from the recent past.
- 20 October 2022
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 160 (2) , 709-710
Increased pregnancy‐related death and disease: A neglected aspect of restricting abortions
- 20 October 2022
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 160 (2) , 709-710
Increased pregnancy‐related death and disease: A neglected aspect of restricting abortions